Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
23.04
+1.11 (5.06%)
At close: Jan 21, 2025, 4:00 PM
23.00
-0.04 (-0.17%)
After-hours: Jan 21, 2025, 5:08 PM EST
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.32 billion as of January 21, 2025. Its market cap has increased by 18.02% in one year.
Market Cap
3.32B
Enterprise Value
2.09B
1-Year Change
18.02%
Ranking
Category
Stock Price
$23.04
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.32B, an increase of 75.71%. That is a compound annual growth rate of 8.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 653.46B |
UnitedHealth Group | 469.12B |
Johnson & Johnson | 353.99B |
Novo Nordisk | 341.33B |
AbbVie | 303.17B |
Merck & Co. | 247.70B |
Thermo Fisher Scientific | 214.07B |
Intuitive Surgical | 211.09B |